Latest / The Well-Built Life / Lab Tests & Your Health: Beyond the Report Card
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to the Well Built Life. I
- 0:03Speaker 1: am Rachel Caldwell, alongside Thomas Bennett, and we are so
- 0:07Speaker 1: glad you are tuning in. We are here to cut
- 0:09Speaker 1: through the noise, skip the intense jargon and extreme rules,
- 0:13Speaker 1: and share simple practical habits that help you feel stronger, healthier,
- 0:18Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:22Speaker 1: and let's dive in. So, Rachel, when patients walk into
- 0:25Speaker 1: that first lab call, They often have this idea that
- 0:28Speaker 1: their blood work will give them a clear, comprehensive answer
- 0:31Speaker 1: about their overall health. But it's not quite that straightforward,
- 0:36Speaker 1: is it, Thomas? How do you see patients' initial expectations
- 0:40Speaker 1: aligning with what's actually achievable through lab results?
- 0:43Speaker 2: Exactly, because on the surface it looks straightforward, but when
- 0:46Speaker 2: you dig into the mechanics, the incentives tell a very
- 0:50Speaker 2: different story. Thomas here is referring to the fact that
- 0:53Speaker 2: patients often enter that first lab call with high hopes
- 0:56Speaker 2: for a comprehensive snapshot of their health. Think of it
- 0:59Speaker 2: like trying to check the status of a whole car
- 1:01Speaker 2: just by looking at a single gauge. Right.
- 1:05Speaker 1: If you look at the capital flows over the past quarter,
- 1:08Speaker 1: it's clear that patients' expectations are often fueled by the
- 1:12Speaker 1: marketing messaging from direct-to-consumer labs. But it's actually quite complex
- 1:17Speaker 1: when you consider the limitations of these tests. For example
- 1:20Speaker 1: … Reference ranges, though, are the normal values based on
- 1:24Speaker 1: large population studies, aren't always indicative of an individual's optimal health.
- 1:29Speaker 2: That's wild when you look at the raw numbers. A
- 1:32Speaker 2: lot of folks might be within the reference range but
- 1:35Speaker 2: still have underlying issues. Take a marker like C-reactive protein, CRP,
- 1:39Speaker 2: for instance. Elevated levels can hint at inflammation, but without
- 1:44Speaker 2: the full context of a person's lifestyle, those numbers can
- 1:47Speaker 2: be misleading.
- 1:48Speaker 1: Exactly. And there are also genetic factors to consider. Tests
- 1:53Speaker 1: like APOE and APOB can give insights into potential cardiovascular risk.
- 1:59Speaker 1: But they are just one piece of the puzzle. It's
- 2:01Speaker 1: not just about the numbers. It's about understanding the broader
- 2:05Speaker 1: picture of a person's health.
- 2:06Speaker 2: Agreed. That's where the concept of longevity comes in. It's
- 2:10Speaker 2: not just about how long you live, but how well
- 2:13Speaker 2: you live. You know, the combined longevity factors include both
- 2:17Speaker 2: lifespan and healthspan. This nuance is crucial for a more
- 2:21Speaker 2: holistic approach to health.
- 2:23Speaker 1: Right, and that's the crucial nuance here. It's about understanding
- 2:27Speaker 1: that lab tests, while important, don't provide the whole picture.
- 2:31Speaker 1: For example, cardiovascular disease is often a slow process influenced
- 2:35Speaker 1: by multiple factors. Blood tests can identify risk factors, but
- 2:40Speaker 1: they can't capture the dynamic interplay of lifestyle, diet, and environment.
- 2:45Speaker 2: Exactly, which brings up an interesting contradiction. Patients often seek
- 2:50Speaker 2: definitive answers, but we as healthcare providers know that lab
- 2:54Speaker 2: results alone aren't enough. We need to consider genetic, lifestyle,
- 2:59Speaker 2: and environmental factors to really understand a patient's health status.
- 3:03Speaker 1: True, and let's not forget the value of a more
- 3:06Speaker 1: comprehensive evaluation. For instance, even when a patient's labs come
- 3:11Speaker 1: back within the normal range, their overall health picture may
- 3:15Speaker 1: still be impacted by mental health, physical fitness, and other
- 3:19Speaker 1: non-lab indicators. This is why we emphasize the importance of
- 3:23Speaker 1: longitudinal data tracking trends over time can provide more meaningful insights.
- 3:29Speaker 2: That's a great point, Rachel. It highlights the need for
- 3:32Speaker 2: a more integrated approach. For example, having a patient come
- 3:35Speaker 2: in every few months to compare current and previous lab
- 3:38Speaker 2: work can give us a clearer understanding of their health trajectory.
- 3:42Speaker 2: It's all about managing these expectations and providing a tailored
- 3:45Speaker 2: care plan that includes both lab results and other health indicators.
- 3:49Speaker 1: So, let's dive into the nitty-gritty of lab tests. Often,
- 3:53Speaker 1: patients walk into those labs with this idea that a
- 3:57Speaker 1: blood sample alone will tell them everything they need to know.
- 4:00Speaker 1: But Thomas, isn't it the case that these tests can
- 4:03Speaker 1: only provide a snapshot? What are the limitations we should
- 4:06Speaker 1: keep in mind?
- 4:07Speaker 2: Exactly, Rachel. The snapshot concept is crucial. Lab tests are
- 4:12Speaker 2: essential tools, but they are far from comprehensive. For instance,
- 4:16Speaker 2: consider the reference ranges. They indicate what's normal, but what
- 4:20Speaker 2: we see is just a window into one moment in time,
- 4:24Speaker 2: not the whole picture.
- 4:25Speaker 1: Right. Take cholesterol levels, for example. While elevated LDL can
- 4:29Speaker 1: indicate high risk, it's just one piece of the puzzle.
- 4:33Speaker 1: High blood pressure, family history, lifestyle. A multitude of factors
- 4:37Speaker 1: play a role. How do we reconcile this with patient expectations?
- 4:41Speaker 2: Well, it's about managing those expectations. Think of it like
- 4:45Speaker 2: a marathon rather than a sprint. Lab results are like
- 4:49Speaker 2: the first mile, but to truly assess overall health, we
- 4:53Speaker 2: need to look at the full journey. Longitudinal data is
- 4:56Speaker 2: key here, showing trends over time.
- 4:58Speaker 1: Absolutely, but let's probe deeper into the mechanisms. Take cardiac
- 5:03Speaker 1: health for example. Lab tests like C-reactive protein, CRP, can
- 5:08Speaker 1: indicate inflammation, a major risk factor for heart disease. However,
- 5:13Speaker 1: CRP can be elevated for other reasons too. How do
- 5:16Speaker 1: we avoid false positives?
- 5:18Speaker 2: That's a great point. The tricky part is differentiating. A
- 5:22Speaker 2: high CRP could signal inflammation from heart disease, but it
- 5:25Speaker 2: could also be due to arthritis or a recent viral infection.
- 5:30Speaker 2: So we need to contextualize these results within the patient's
- 5:33Speaker 2: broader health landscape.
- 5:34Speaker 1: Context is indeed everything. and it leads us to the
- 5:38Speaker 1: broader concept of longevity. You mentioned lifespan and healthspan earlier.
- 5:44Speaker 1: Can you elaborate on the implications this has for health management?
- 5:48Speaker 2: Sure. Lifespan is about living longer while healthspan is about
- 5:53Speaker 2: living well. For example, someone could live a long life
- 5:57Speaker 2: with chronic illness, which is not ideal. What we want
- 6:00Speaker 2: is a longer, more vibrant life. Lab tests help, but
- 6:05Speaker 2: they're only part of the equation. We need to integrate physical, cognitive,
- 6:10Speaker 2: and emotional health for a holistic view. True.
- 6:13Speaker 1: And this ties in with the idea of differential diagnosis.
- 6:17Speaker 1: We can't just look at one lab value or health
- 6:20Speaker 1: indicator in isolation. It's about considering everything from genetics to lifestyle.
- 6:27Speaker 1: And how they interplay.
- 6:28Speaker 2: Exactly. Take a POE or APOB genetic tests. While they
- 6:32Speaker 2: provide some insights, they are not definitive. They are another
- 6:36Speaker 2: tool in the kit, but we can't rely solely on
- 6:39Speaker 2: these genetic markers. We need to see how environmental and
- 6:42Speaker 2: lifestyle factors interact with them.
- 6:44Speaker 1: And this leads us to another challenge. The rapid rise
- 6:48Speaker 1: of direct-to-consumer DTC labs. While they offer convenience, they can
- 6:54Speaker 1: set unmanageable expectations. What role do you think these labs
- 6:58Speaker 1: play in the broader health narrative?
- 7:00Speaker 2: DTC labs are a double-edged sword. They democratize access to
- 7:05Speaker 2: health information, which is positive, but they can also lead
- 7:09Speaker 2: to misinterpretation and undue anxiety. It's a balancing act education
- 7:15Speaker 2: for patients on how to use these tests responsibly is crucial.
- 7:19Speaker 1: That's a fair point, and we should also discuss the
- 7:22Speaker 1: cost implications. Longitudinal data isn't cheap, and it requires robust records.
- 7:28Speaker 1: Is it sustainable for most healthcare systems? To manage this complexity?
- 7:33Speaker 2: The economics of longitudinal data are indeed complex. But with technology,
- 7:38Speaker 2: we are seeing more automated solutions that can help streamline
- 7:42Speaker 2: data management. It's about finding effective, patient-centric approaches.
- 7:47Speaker 1: Absolutely. In the end, it's all about balancing the limitations
- 7:51Speaker 1: of lab tests with the broader context. Like you said, Thomas,
- 7:55Speaker 1: it's a marathon, not a sprint. We need to educate
- 7:59Speaker 1: patients and healthcare providers alike to manage these expectations sensibly.
- 8:04Speaker 2: Precisely, Rachel. The goal is to use lab tests as
- 8:07Speaker 2: they should be tools that provide insights, not definitive answers.
- 8:11Speaker 2: We need a more integrated, holistic approach to truly understand
- 8:14Speaker 2: and manage health.
- 8:15Speaker 1: When you look at the current debate on direct-to-consumer, DTC
- 8:19Speaker 1: lab testing, it's clear that tears a significant gap between
- 8:22Speaker 1: patient expectations and what these tests actually reveal. Thomas. Do
- 8:27Speaker 1: you see patients coming in with unrealistic beliefs about what
- 8:31Speaker 1: they can learn from a home test kit?
- 8:33Speaker 2: Absolutely, Rachel. Many people see DTC lab testing as a panacea,
- 8:38Speaker 2: thinking they can diagnose everything from their couch. But it's
- 8:41Speaker 2: a bit like trying to read a book by flipping
- 8:44Speaker 2: through random pages useful sometimes, but not as comprehensive as
- 8:48Speaker 2: a full read-through.
- 8:49Speaker 1: And it's not just about unrealistic expectations to raise also
- 8:53Speaker 1: the issue of how these tests are marketed. The narratives
- 8:57Speaker 1: often highlight the convenience without fully addressing the limitations. How
- 9:01Speaker 1: does this impact the relationship between patients and healthcare providers?
- 9:05Speaker 2: That's a great point. The marketing of DTC tests tends
- 9:09Speaker 2: to downplay the need for context and longitudinal data. For example,
- 9:13Speaker 2: a single TRP level might indicate inflammation, but without understanding
- 9:17Speaker 2: the patient's full health profile, it's tough to know if
- 9:20Speaker 2: it's a one-off or a chronic concern.
- 9:23Speaker 1: Exactly, and this is where the contradictions really start. On
- 9:27Speaker 1: one hand, we have the allure of immediate accessible answers.
- 9:31Speaker 1: On the other, we have the complexities of comprehensive healthcare,
- 9:36Speaker 1: where labs are just one piece of the puzzle. Right.
- 9:39Speaker 2: And it's not just about the marketing. Healthcare providers are
- 9:42Speaker 2: caught between providing the best care and managing the limitations
- 9:46Speaker 2: of what these tests can do. They face the challenge
- 9:49Speaker 2: of educating patients about the nuances of interpreting lab results.
- 9:53Speaker 1: True. And the stakes are high. When patients rely solely
- 9:57Speaker 1: on DTC testing, they might miss crucial markers that could
- 10:01Speaker 1: be easily caught in a more thorough evaluation. It's about
- 10:04Speaker 1: striking the right balance, but often patients and providers go
- 10:08Speaker 1: to extremes, leading to misunderstandings and misdiagnoses.
- 10:12Speaker 2: Precisely. It's a delicate dance. For instance, a patient might
- 10:16Speaker 2: see a high LDL level on a DTC test and
- 10:19Speaker 2: become overly worried, neglecting other factors like their overall lifestyle. Conversely,
- 10:24Speaker 2: a provider might dismiss the value of home test kits,
- 10:27Speaker 2: missing out on the convenience and accessibility they offer.
- 10:30Speaker 1: Terry is also the psychological aspect. The anxiety generated by
- 10:34Speaker 1: home tests can be detrimental, even if the results are
- 10:38Speaker 1: not as dire as feared. Meanwhile … Patients might ignore
- 10:42Speaker 1: the lab tests they receive during routine visits if they
- 10:45Speaker 1: have doubts about their value.
- 10:47Speaker 2: That's a good point. It goes to show that we
- 10:50Speaker 2: need to ensure patients understand the value of both types
- 10:53Speaker 2: of testing home and professional. We need to teach them
- 10:56Speaker 2: to look at the bigger picture rather than getting hung
- 10:59Speaker 2: up on single numbers.
- 11:00Speaker 1: Absolutely. And this is where the conversation with Peter Attia
- 11:04Speaker 1: becomes crucial. He often stresses the importance of context and
- 11:09Speaker 1: longitudinal data. which is something DTC labs struggle to provide effectively.
- 11:15Speaker 1: It's about building a more holistic understanding of health.
- 11:18Speaker 2: Yes, and it's important to frame this not just as
- 11:21Speaker 2: a limitation of DTC testing, but as a need for
- 11:24Speaker 2: a more integrated approach that balances the benefits of accessibility
- 11:29Speaker 2: with the comprehensive care provided by traditional methods.
- 11:32Speaker 1: So, let's dive into the future outlooks and unsolved questions
- 11:36Speaker 1: regarding DTC labs and advanced technology in healthcare.
- 11:39Speaker 2: Thomas.
- 11:40Speaker 1: How do you see the integration of these technologies evolving
- 11:43Speaker 1: over the next decade, specifically in terms of patient education
- 11:47Speaker 1: and realistic expectations?
- 11:49Speaker 2: Absolutely. I think it's crucial to address patient education first,
- 11:54Speaker 2: right now to raise a significant gap between what DTC
- 11:57Speaker 2: testing promises and what it actually delivers. For example, many
- 12:01Speaker 2: individuals might see a high C-reactive protein CRP level and
- 12:05Speaker 2: assume they are at risk for severe inflammation without considering
- 12:09Speaker 2: other factors. We need to create more nuanced educational materials
- 12:13Speaker 2: to prepare patients for these realities.
- 12:16Speaker 1: Exactly. That's the tricky part. And it shouldn't just be
- 12:19Speaker 1: a one-time education session. Ongoing communication and updates are key.
- 12:25Speaker 1: How do you think advancements in technology can help bridge
- 12:28Speaker 1: this gap? For instance, could AI play a role in
- 12:32Speaker 1: providing more personalized feedback?
- 12:34Speaker 2: Absolutely. AI could be a game changer. It could help
- 12:38Speaker 2: in delivering real-time, personalized insights based on a patient's historical
- 12:42Speaker 2: data and current health status. For example, imagine a system
- 12:47Speaker 2: that not only flags potential issues but also suggests lifestyle
- 12:50Speaker 2: adjustments or further testing based on the patient's unique profile.
- 12:54Speaker 2: This could help patients better understand their health over time.
- 12:58Speaker 1: That's a promising idea. Now, considering the various stakeholders' patients, providers,
- 13:05Speaker 1: and DTC labs, How do you foresee the future of
- 13:08Speaker 1: collaboration between these entities? Do you think there will be
- 13:12Speaker 1: more of a push towards integrated solutions?
- 13:14Speaker 2: I definitely see room for collaboration, but there are also challenges.
- 13:19Speaker 2: On the one hand, providers can benefit from DTC lab
- 13:22Speaker 2: results as part of a broader health picture, especially if
- 13:25Speaker 2: that data is securely integrated into their systems. On the
- 13:29Speaker 2: other hand, patients often feel a disconnect if they don't
- 13:33Speaker 2: see their DTC results aligned with their inoffice evaluations. Finding
- 13:37Speaker 2: a balance where both parties see value is key.
- 13:40Speaker 1: Right. And this leads to another unsolved question. How can
- 13:44Speaker 1: we ensure that DTC labs are not just a convenience,
- 13:48Speaker 1: but a legitimate part of the healthcare ecosystem? Perhaps through
- 13:52Speaker 1: clearer regulations and standards that ensure transparency and accuracy.
- 13:57Speaker 2: Exactly. Clarity and accuracy are paramount. We need to establish
- 14:02Speaker 2: clearer guidelines for what information DTC labs can and can't claim.
- 14:07Speaker 2: For example, if a lab can't definitively diagnose a condition,
- 14:12Speaker 2: they shouldn't be able to market their tests as such.
- 14:15Speaker 2: This would help build trust and ensure that patients are
- 14:18Speaker 2: making informed decisions.
- 14:19Speaker 1: That's a sensible approach. Now, looking ahead, what role should
- 14:24Speaker 1: advanced technology play in mitigating the limitations of current lab testing?
- 14:30Speaker 1: AI and machine learning seem like obvious candidates. But are
- 14:34Speaker 1: there other innovative solutions that could also contribute?
- 14:37Speaker 2: Indeed, AI and machine learning are essential, but we shouldn't
- 14:41Speaker 2: overlook other advancements. For instance, wearable tech and continuous health
- 14:47Speaker 2: monitoring devices can provide real-time data that lab tests might miss,
- 14:51Speaker 2: offering a more holistic view of a patient's health. Additionally,
- 14:55Speaker 2: blockchain could enhance data security and interoperability. making it easier
- 15:01Speaker 2: for different healthcare systems to share and verify patient data.
- 15:05Speaker 1: Those are all great points, and it's clear that we
- 15:07Speaker 1: need a multifaceted approach to address these challenges. The future
- 15:12Speaker 1: of DTC labs and healthcare technology lies in creating a
- 15:16Speaker 1: seamless integrated system that respects the limits of what lab
- 15:20Speaker 1: tests can do while leveraging advanced technology. to provide a
- 15:25Speaker 1: more comprehensive picture of individual health.
- 15:27Speaker 2: So, let's draw this conclusion by addressing the strategic implications
- 15:32Speaker 2: of what we have discussed today. One critical takeaway is
- 15:36Speaker 2: the importance of a comprehensive health evaluation, which should be
- 15:40Speaker 2: the cornerstone of patient care. Lab tests are essential, but
- 15:44Speaker 2: they are just one piece of the puzzle, right?
- 15:47Speaker 1: Exactly, Thomas. A holistic approach is crucial. For instance, Consider
- 15:52Speaker 1: how longitudinal data can provide deeper insights. We can understand
- 15:56Speaker 1: chronic diseases better through this method. A single snapshot of
- 16:00Speaker 1: blood test results, especially for conditions like cardiovascular disease, might
- 16:04Speaker 1: miss subtle indicators over time.
- 16:06Speaker 2: Agreed. Let's take cardiovascular disease as an example. It's a
- 16:11Speaker 2: prime case where lab tests alone can't tell the whole story.
- 16:14Speaker 2: A comprehensive health evaluation would look at lifestyle factors, genetic predispositions,
- 16:21Speaker 2: environmental exposures, and mental well-being. Lab tests for markers like
- 16:26Speaker 2: C-reactive protein and LDL cholesterol are certainly valuable, but they
- 16:31Speaker 2: should be interpreted within the context of a broader assessment.
- 16:34Speaker 1: That's spot on. And the value of genetic tests, like
- 16:38Speaker 1: APOE and APOB, can't be overstated. They can identify genetic
- 16:43Speaker 1: risk factors that lab tests might miss. For instance, an
- 16:47Speaker 1: elevated APOE4 genotype can significantly increase the risk of Alzheimer's disease.
- 16:54Speaker 1: Yet it's not something a routine blood panel will typically reveal.
- 16:57Speaker 2: True. That's why integrating various forms of data genetic, lifestyle,
- 17:02Speaker 2: environmental into a single health evaluation is vital. It's not
- 17:07Speaker 2: just about diagnosing. It's about managing health. Comprehensive evaluations can
- 17:12Speaker 2: help patients understand their full spectrum of risk factors and
- 17:16Speaker 2: empower them to make informed choices.
- 17:18Speaker 1: Exactly. And speaking of empowering patients, we must also consider
- 17:23Speaker 1: their education. How do we help patients manage their expectations
- 17:27Speaker 1: and understand that lab results are just one component of
- 17:30Speaker 1: their overall health picture? It's a challenge, but essential.
- 17:34Speaker 2: Absolutely. One strategy is to educate patients about the limitations
- 17:38Speaker 2: of DTC lab tests. While they can provide some insights,
- 17:42Speaker 2: they shouldn't be seen as a substitute for a thorough evaluation.
- 17:46Speaker 2: This can help prevent patients from making decisions based on
- 17:50Speaker 2: incomplete information.
- 17:51Speaker 1: And when it comes to integrating DTC labs into healthcare,
- 17:54Speaker 1: we need to view them as supplementary tools. They can
- 17:57Speaker 1: offer convenience and accessibility, but they shouldn't replace in-person evaluations.
- 18:03Speaker 1: The future lies in leveraging DTC labs to augment, not replace,
- 18:08Speaker 1: professional care.
- 18:09Speaker 2: Right. We need to strike a balance. DTC labs can
- 18:13Speaker 2: provide initial screenings. But follow-up should always involve a healthcare provider.
- 18:18Speaker 2: This dual approach allows us to leverage technology while maintaining
- 18:22Speaker 2: the integrity of comprehensive patient care.
- 18:24Speaker 1: Indeed. And with AI and machine learning advancements, we can
- 18:29Speaker 1: start to interpret lab data more granularly, providing personalized insights
- 18:33Speaker 1: that can be integrated into a patient's care plan. This
- 18:37Speaker 1: technology can help bridge the gap between DTC lab tests
- 18:41Speaker 1: and traditional healthcare.
- 18:42Speaker 2: Exactly. It's about creating a seamless, integrated system that respects
- 18:47Speaker 2: the limits of lab tests while leveraging advanced technology for
- 18:50Speaker 2: a more comprehensive picture of individual health. This future model
- 18:54Speaker 2: would truly value both the quantitative data from lab tests
- 18:57Speaker 2: and the qualitative insights from patient history and lifestyle assessments.
- 19:01Speaker 1: That brings us to the end of today's episode. Thank
- 19:04Speaker 1: you so much for spending part of your day with me.
- 19:07Speaker 1: If you found this episode's tips helpful and want to
- 19:09Speaker 1: make sure you don't miss the next conversation, Please take
- 19:12Speaker 1: a quick second to hit that subscribe or follow button
- 19:15Speaker 1: on whatever platform you are listening on. It's a completely
- 19:19Speaker 1: free way to support the show and helps more people
- 19:21Speaker 1: find us. This podcast is independently produced, so if you
- 19:25Speaker 1: are ever in a position where you would like to
- 19:27Speaker 1: help keep it running, we do accept small donations. You
- 19:31Speaker 1: can find a link right in the episode description below
- 19:34Speaker 1: to buy us a coffee or contribute what you can.
- 19:38Speaker 1: Every bit genuinely helps. Take care of yourself. Stay balanced.
- 19:42Speaker 1: And we will talk again soon.